Evidence map›Paper›PMID 27514610›Full record

ArticleMicrobial cell factories2016

Heterologous expression of antigenic peptides in Bacillus subtilis biofilms.

Cédric M Vogt, Elisabeth M Schraner, Claudio Aguilar, Catherine Eichwald

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. The P4' Peptide-CarryingAquaculture nutrition · 2024
    Article
  3. The Bacterial Spore as a Mucosal Vaccine Delivery System.International journal of molecular sciences · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Cédric M VogtInstitute of Virology, University of Zurich, Winterthurerstrasse 266a, 8057, Zurich, Switzerland.
Elisabeth M SchranerInstitute of Virology, University of Zurich, Winterthurerstrasse 266a, 8057, Zurich, Switzerland.
Claudio Aguilarrqmicro Ltd, ETH, Otto-Stern-Weg 7, 8093, Zurich, Switzerland. aguilar@rqmicro.ch.
Catherine EichwaldInstitute of Virology, University of Zurich, Winterthurerstrasse 266a, 8057, Zurich, Switzerland. ceichwald@vetvir.uzh.ch.ORCID http://orcid.org/0000-0003-0001-4843
University of Zurich · CHETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNumerous strategies have been developed for the display of heterologous proteins in the surface of live bacterial carriers, which can be used as vaccines, immune-modulators, cancer therapy or bioremediation. Bacterial biofilms have emerged as an interesting approach for the expression of proteins of interest. Bacillus subtilis is a well-described, endospore-forming organism that is able to form biofilms and also used as a probiotic, thus making it a suitable candidate for the display of heterologous proteins within the biofilm. Here, we describe the use of TasA, an important structural component of the biofilms formed by B. subtilis, as a genetic tool for the display of heterologous proteins.

resultsWe first engineered the fusion protein TasA-mCherry and showed that was widely deployed within the B. subtilis biofilms. A significant enhancement of the expression of TasA-mCherry within the biofilm was obtained when depleting both tasA and sinR genes. We subsequently engineered fusion proteins of TasA to antigenic peptides of the E. granulosus parasite, paramyosin and tropomyosin. Our results show that the antigens were well expressed within the biofilm as denoted by macrostructure complementation and by the detection of the fusion protein in both immunoblot and immunohistochemistry. In addition, we show that the recombinant endospores of B. subtilis preserve their biophysical and morphological properties.

conclusionsIn this work we provide strong evidence pointing that TasA is a suitable candidate for the display of heterologous peptides, such as antigens, cytokines, enzymes or antibodies, in the B. subtilis biofilms. Finally, our data portray that the recombinant endospores preserve their morphological and biophysical properties and could be an excellent tool to facilitate the transport and the administration.

Indexed as

BiofilmsAnimalsAntigens, HelminthBacillus subtilisBacterial ProteinsEchinococcus granulosusHelminth ProteinsImmunohistochemistryLuminescent ProteinsOperonPeptide FragmentsRecombinant Fusion ProteinsRed Fluorescent ProteinSpores, BacterialTropomyosinAntigens, HelminthBacterial ProteinsFlaD protein, BacteriaHelminth ProteinsLuminescent ProteinsPeptide FragmentsRecombinant Fusion ProteinsRed Fluorescent ProteinTasA protein, Bacillus subtilisTropomyosinAntigenBacillus subtilisBiofilmE. granulosusEndosporesHeterologous proteinmCherryParamyosinTasATropomyosin

Identifiers

PMID27514610
PMCPMC4982213
OpenAlexW2518580400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.